台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    92.3
  • 漲跌
    ▲0.6
  • 漲幅
    +0.65%
  • 成交量
    256
  • 產業
    上櫃 生技醫療類股▲0.83%
  • 302人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-富邦-景美 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-景美 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/09/11184.1000.0084.1011,0550.09%
2023/09/011388.4910.389.6589.102.71,0710.25%
2023/08/230.386.7000.0085.500.31,0600.03%
2023/08/1700.000.186.7084.90-0.11,109-0.01%
2023/08/1600.00486.0887.00-41,094-0.37%
2023/08/1000.00283.6083.50-21,068-0.19%
2023/08/0900.00384.9784.90-31,090-0.28%
2023/08/07184.0000.0085.7011,1160.09%
2023/08/02183.0000.0081.9011,1330.09%
2023/08/01185.2000.0084.9011,1260.09%
2023/07/2800.000.185.5085.40-0.11,167-0.01%
2023/07/27286.6500.0086.2021,1680.17%
2023/07/261.385.0200.0085.001.31,1800.11%
2023/07/25285.50187.6087.5011,1720.09%
2023/07/24186.0000.0086.0011,1590.09%
2023/07/1900.000.389.8789.80-0.31,192-0.03%
2023/07/182.389.3700.0087.202.31,2310.19%
2023/07/1400.001588.4388.20-151,280-1.17%
2023/07/13385.3000.0085.1031,2700.24%
2023/07/123.386.7400.0086.003.31,2730.26%
2023/07/11988.99288.3087.8071,2730.55%
2023/07/10692.73293.1092.0041,2440.32%
2023/07/07193.60294.1093.80-11,247-0.08%
2023/06/3000.00197.4097.50-11,342-0.07%
2023/06/2900.00197.3096.80-11,352-0.07%
2023/06/27194.4000.0094.6011,4280.07%
2023/06/2600.00194.4093.30-11,469-0.07%
2023/06/2100.00193.6093.40-11,543-0.06%
2023/06/20293.3000.0093.2021,5490.13%
2023/06/19194.8000.0094.4011,5530.06%
2023/06/1600.00194.2094.10-11,553-0.06%
2023/06/15392.80193.7093.2021,5560.13%
2023/06/14294.1000.0093.1021,5680.13%
2023/06/09195.7000.0095.9011,6580.06%
2023/06/0700.00296.9596.50-21,725-0.12%
2023/06/06194.8000.0094.9011,7470.06%
2023/05/30192.80192.6092.6001,8610.00%
2023/05/2900.00093.3093.5001,8750.00%
2023/05/2600.00094.2093.3001,8910.00%
2023/05/24296.0800.0096.3021,9490.10%
2023/05/230100.0000.0099.0001,9430.00%
2023/05/2200.00194.8095.30-11,968-0.05%
2023/05/19294.4000.0093.4022,0010.10%
2023/05/18194.70195.7794.8002,0240.00%
2023/05/17096.3000.0094.6002,0470.00%
2023/05/12194.60195.0094.7002,1450.00%
2023/05/11197.0000.0096.7012,2790.04%
2023/05/09198.0000.0096.9012,4610.04%
2023/05/082100.3500.0099.6022,5590.08%
2023/05/052102.5000.00101.5022,6320.08%
2023/05/0400.001102.00101.50-12,706-0.04%
2023/05/03199.501100.0099.5002,7310.00%
2023/05/021100.001100.50100.5002,8090.00%
2023/04/2700.00195.1096.00-12,938-0.03%
2023/04/255101.00997.0397.00-43,132-0.13%
2023/04/213102.173100.1398.2003,3150.00%
2023/04/205107.506104.67103.50-13,315-0.03%
2023/04/198105.948106.56107.0003,3680.00%
2023/04/171105.0000.00105.0013,5340.03%
2023/04/144106.631108.00106.0033,7330.08%
2023/04/132108.002108.00108.0003,8220.00%
2023/04/1200.001109.00107.00-13,940-0.03%
2023/04/111106.5000.00106.5014,0520.02%
2023/04/104107.2500.00107.0044,1560.10%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章